Apolipoprotein A-V level may contribute to the development of obesity-associated dyslipidemia - 22/09/13
Summary |
Aim |
In a mice study, insulin suppressed apolipoprotein A-V (apoA-V) gene expression in a dose dependent manner. Thus, we investigated the association between apoA-V levels and dyslipidemias in obese children with hyperinsulinemia.
Methods |
The subjects were 17 obese children (15 male, 2 female) aged 11.8±2.4 years. Total cholesterol (TC), high-density lipoprotein cholesterol (HDLC), triglyceride (TG), apoA-V and insulin levels were determined.
Results |
Obese children with hyperinsulinemia had greater percent overweight, higher TG level, lower HDLC level and lower apoA-V level than those without hyperinsulinemia. In simple regression analysis, apoA-V level correlated negatively with TG (r=−0.613, p=0.0152) and insulin levels (r=−0.566, p=0.0279), and positively correlated with HDLC (r=0.811, p=0.0002). In stepwise regression analysis, insulin level emerged as the independent determinant of TG level after apoA-V level was taken into account, whereas apoA-V emerged as the independent determinant of HDLC level after adjusting for insulin level.
Conclusions |
Insulin may be a potent regulator of serum apoA-V level in obesity, and apoA-V level may partly contribute to the development of obesity-associated dyslipidemia.
Le texte complet de cet article est disponible en PDF.Keywords : Obesity, Children, Apolipoprotein A-V, Insulin, Dyslipidemia
Plan
Vol 7 - N° 5
P. e415-e419 - septembre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?